Found: 46
Select item for more details and to access through your institution.
Early experience of atezolizumab plus bevacizumab therapy in Japanese patients with unresectable hepatocellular carcinoma in real-world practice.
- Published in:
- Investigational New Drugs, 2022, v. 40, n. 2, p. 392, doi. 10.1007/s10637-021-01185-4
- By:
- Publication type:
- Article
Concordance between metabolic dysfunction‐associated steatotic liver disease and nonalcoholic fatty liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 600, doi. 10.1111/hepr.14011
- By:
- Publication type:
- Article
Prognostic significance of C‐reactive protein in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
- Published in:
- Hepatology Research, 2024, v. 54, n. 6, p. 562, doi. 10.1111/hepr.14001
- By:
- Publication type:
- Article
Alanine aminotransferase levels as therapeutic targets after nucleotide/nucleoside analog therapy in patient with chronic hepatitis B.
- Published in:
- Hepatology Research, 2023, v. 53, n. 1, p. 35, doi. 10.1111/hepr.13839
- By:
- Publication type:
- Article
Prognosis of intrahepatic cholangiocarcinoma stratified by albumin–bilirubin grade.
- Published in:
- Hepatology Research, 2021, v. 51, n. 8, p. 902, doi. 10.1111/hepr.13673
- By:
- Publication type:
- Article
Strategy for advanced hepatocellular carcinoma based on liver function and portal vein tumor thrombosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1375, doi. 10.1111/hepr.13567
- By:
- Publication type:
- Article
Receptor‐Interacting Protein Kinase 3 (RIPK3) inhibits autophagic flux during necroptosis in intestinal epithelial cells.
- Published in:
- FEBS Letters, 2020, v. 594, n. 10, p. 1586, doi. 10.1002/1873-3468.13748
- By:
- Publication type:
- Article
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2022, v. 17, n. 3, p. 1, doi. 10.1371/journal.pone.0265235
- By:
- Publication type:
- Article
The impact of background liver disease on the long-term prognosis of very-early-stage HCC after ablation therapy.
- Published in:
- PLoS ONE, 2022, v. 17, n. 2, p. 1, doi. 10.1371/journal.pone.0264075
- By:
- Publication type:
- Article
A Comparison of Alanine Aminotransferase Normalization between Pemafibrate and Bezafibrate in Patients with Nonalcoholic Fatty Liver Disease.
- Published in:
- Internal Medicine, 2024, v. 63, n. 9, p. 1185, doi. 10.2169/internalmedicine.2248-23
- By:
- Publication type:
- Article
Add-on Therapeutic Effects of Rifaximin on Treatment-resistant Hepatic Encephalopathy.
- Published in:
- Internal Medicine, 2023, v. 62, n. 7, p. 973, doi. 10.2169/internalmedicine.0212-22
- By:
- Publication type:
- Article
Wisteria floribunda Agglutinin-Positive Mac-2 Binding Protein as a Screening Tool for Significant Liver Fibrosis in Health Checkup.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 1, p. 40, doi. 10.3390/ijms22010040
- By:
- Publication type:
- Article
Validation of albumin, bilirubin, and platelet criteria for avoiding screening endoscopy in patients with advanced fibrosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 8, p. 996, doi. 10.1111/hepr.13533
- By:
- Publication type:
- Article
Three criteria for radiological response on survival in patients with hepatocellular carcinoma treated with lenvatinib.
- Published in:
- Hepatology Research, 2020, v. 50, n. 1, p. 137, doi. 10.1111/hepr.13416
- By:
- Publication type:
- Article
Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy.
- Published in:
- Cancer Reports, 2022, v. 5, n. 11, p. 1, doi. 10.1002/cnr2.1613
- By:
- Publication type:
- Article
A Novel OGR1 (GPR68) Inhibitor Attenuates Inflammation in Murine Models of Colitis.
- Published in:
- Inflammatory Intestinal Diseases, 2021, v. 6, n. 3, p. 140, doi. 10.1159/000517474
- By:
- Publication type:
- Article
Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 297, doi. 10.1111/jvh.13805
- By:
- Publication type:
- Article
Dynamic evaluation of hepatocellular carcinoma prediction models in patients with chronic hepatitis B receiving nucleotide/nucleoside analogue treatment.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 5, p. 787, doi. 10.1111/jvh.13473
- By:
- Publication type:
- Article
Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 55, n. 3, p. 292, doi. 10.1111/apt.16745
- By:
- Publication type:
- Article
5‐aminosalicylate–intolerant patients are at increased risk of colectomy for ulcerative colitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 53, n. 1, p. 103, doi. 10.1111/apt.16120
- By:
- Publication type:
- Article
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Impaired brain function improved by l-carnitine in patients with cirrhosis: evaluation using near-infrared spectroscopy.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-70585-y
- By:
- Publication type:
- Article
Angiosarcoma Involving Solid Organs and the Gastrointestinal Tract with Life-Threatening Bleeding.
- Published in:
- Case Reports in Gastroenterology, 2012, v. 6, n. 3, p. 772, doi. 10.1159/000346398
- By:
- Publication type:
- Article
Changes of liver stiffness measured by magnetic resonance elastography during direct‐acting antivirals treatment in patients with chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2021, v. 93, n. 6, p. 3744, doi. 10.1002/jmv.26490
- By:
- Publication type:
- Article
Comparison of medication adherence and satisfaction between entecavir and tenofovir alafenamide therapy in chronic hepatitis B.
- Published in:
- Journal of Medical Virology, 2020, v. 92, n. 8, p. 1355, doi. 10.1002/jmv.25692
- By:
- Publication type:
- Article
Magnetic resonance elastography for the prediction of hepatocellular carcinoma in chronic hepatitis B.
- Published in:
- JGH Open, 2024, v. 8, n. 4, p. 1, doi. 10.1002/jgh3.13067
- By:
- Publication type:
- Article
Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B.
- Published in:
- JGH Open, 2023, v. 7, n. 8, p. 567, doi. 10.1002/jgh3.12950
- By:
- Publication type:
- Article
Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension.
- Published in:
- JGH Open, 2022, v. 6, n. 11, p. 774, doi. 10.1002/jgh3.12821
- By:
- Publication type:
- Article
Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.
- Published in:
- JGH Open, 2022, v. 6, n. 5, p. 301, doi. 10.1002/jgh3.12735
- By:
- Publication type:
- Article
Tenofovir alafenamide for prevention and treatment of hepatitis B virus reactivation and de novo hepatitis.
- Published in:
- JGH Open, 2021, v. 5, n. 9, p. 1085, doi. 10.1002/jgh3.12636
- By:
- Publication type:
- Article
Early radiological response evaluation with response evaluation criteria in solid tumors 1.1 stratifies survival in hepatocellular carcinoma patients treated with lenvatinib.
- Published in:
- JGH Open, 2020, v. 4, n. 6, p. 1183, doi. 10.1002/jgh3.12420
- By:
- Publication type:
- Article
Hepatitis B surface antigen reduction as a result of switching from long‐term entecavir administration to tenofovir.
- Published in:
- JGH Open, 2020, v. 4, n. 3, p. 429, doi. 10.1002/jgh3.12273
- By:
- Publication type:
- Article
The ubiquitin hybrid gene UBA52 regulates ubiquitination of ribosome and sustains embryonic development.
- Published in:
- Scientific Reports, 2016, p. 36780, doi. 10.1038/srep36780
- By:
- Publication type:
- Article
Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
- Published in:
- Journal of Gastroenterology & Hepatology, 2024, v. 39, n. 6, p. 1183, doi. 10.1111/jgh.16532
- By:
- Publication type:
- Article
Validation of magnetic resonance elastography plus fibrosis‐4 for significant fibrosis in nonalcoholic fatty liver disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 9, p. 1726, doi. 10.1111/jgh.15893
- By:
- Publication type:
- Article
Liver fibrosis and fatty liver as independent risk factors for cardiovascular disease.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 10, p. 2960, doi. 10.1111/jgh.15589
- By:
- Publication type:
- Article
Hepatitis B core‐related antigen predicts disease progression and hepatocellular carcinoma in hepatitis B e antigen‐negative chronic hepatitis B patients.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 10, p. 2943, doi. 10.1111/jgh.15563
- By:
- Publication type:
- Article
Validation of hepatocellular carcinoma risk scores in Japanese chronic hepatitis B cohort receiving nucleot(s)ide analog.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 9, p. 1595, doi. 10.1111/jgh.14990
- By:
- Publication type:
- Article
Clinical Utility of Comprehensive Genomic Profiling in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 719, doi. 10.3390/cancers15030719
- By:
- Publication type:
- Article
Clinical Usefulness of Monitoring Muscle Volume during Atezolizumab Plus Bevacizumab Therapy in Patients with Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143551
- By:
- Publication type:
- Article
Sorafenib-Regorafenib Sequential Therapy in Japanese Patients with Unresectable Hepatocellular Carcinoma—Relative Dose Intensity and Post-Regorafenib Therapies in Real World Practice.
- Published in:
- Cancers, 2019, v. 11, n. 10, p. 1517, doi. 10.3390/cancers11101517
- By:
- Publication type:
- Article
Baseline and Early Predictors of Good Patient Candidates for Second-Line after Sorafenib Treatment in Unresectable Hepatocellular Carcinoma.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1256, doi. 10.3390/cancers11091256
- By:
- Publication type:
- Article
Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma.
- Published in:
- PLoS ONE, 2020, v. 15, n. 4, p. 1, doi. 10.1371/journal.pone.0231828
- By:
- Publication type:
- Article
Plasma Renin Activity Predicts Prognosis and Liver Disease-Related Events in Liver Cirrhosis Patients with Ascites Treated by Tolvaptan.
- Published in:
- Digestive Diseases, 2022, v. 40, n. 4, p. 479, doi. 10.1159/000518099
- By:
- Publication type:
- Article
Acinar Cell Carcinoma of the Pancreas with Colon Involvement.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Risk of cardiovascular disease in lean patients with nonalcoholic fatty liver disease.
- Published in:
- BMC Gastroenterology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12876-023-02848-7
- By:
- Publication type:
- Article